Insurers, Pharma Seek to Share Specialty Drug Info

There is a lot of disagreement about what to do about high drug costs. But in at least one case, frequent foes, insurers and drug companies, agree. Participants in both industries say that if they could communicate with each other before new drugs hit the market, it would ease the pain for insurers and patients.

Part of the reason drug spending is rising is because drug manufacturers are developing more specialty drugs for a small populations of patients. The chemical combinations are complex, therefore expensive, to make.